We are excited to share a new Interpat study on IP in China which will be launched at Tsinghua University on Saturday 9th March 2024 in Beijing.
SOUTH KOREA IP Study – June 12, 2023
We are excited to share a new study : Value of IP for health and growth : The economic benefits of strengthening the innovation environment in South Korea.
AMIIF-FIFARMA Innovation Week, 28-30 March 2023 – March 22, 2023
To commemorate their anniversary, AMIIF will be holding the traditional innovation week. This year it is organised in conjunction with the Latin American Federation of the Pharmaceutical Industry (FIFARMA). There will be participation from several international speakers from WIPO, IFPMA and other organisations including Interpat.
UNPRECEDENTED: The Rapid Innovation Response to COVID-19 and the Role of IP – February 10, 2023
This report tells the story of how COVID-19 vaccines and treatments were rapidly developed and delivered to society, focusing on the enabling role of IP.
The Economic Impact of Changing the Environment for Innovation in Argentina- Applying the lessons of Asia to Latin America – November 17, 2022
Business Times article: How Singapore can lead Biopharma Innovation by Interpat & SAPI – November 17, 2022
IP Pact – April 26, 2021
Medical innovations driven by the biopharmaceutical industry have played a fundamental role in helping people live longer, healthier lives. As the global population’s health needs become increasingly complex, it is ever more essential that we research and develop life-saving medicines and vaccines to meet these challenges. Intellectual Property (IP) has been central to great scientific […]